NVACR | NorthView Acquisition Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0350 - 0.0375
52 Week Range	0.0350 - 0.0375
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	5,962
Average Volume	N/A
Shares Outstanding	5,314,000
Market Cap	185,990
Sector	Financial Services
Industry	Shell Companies
IPO Date	2022-01-24

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA
Website	NVACR

NorthView Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus its search on target businesses in the healthcare sector. The company was incorporated 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.

NVACR's peers: FXCOR, KACLR, NVACW, GLLIR, FEXDR, ALSAR

*Chart delayed

Analyzing fundamentals for NVACR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see NVACR Fundamentals page.

Watching at NVACR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NVACR Technicals page.